Newest first. 5.2k questions across 107 tags.
The specifics, since they change the answer: tirzepatide · a wide-pore C18 column · cagrilintide. The comparison I want does not seem to exist anywhere in a form I…
The particulars: PeptideMeter · Homopeptide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I…
The particulars: vomiting · twelve · a GLP-1 receptor agonist. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this…
Setup, so nobody has to ask: triglycerides · semaglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with…
What I am working with: 99.4% · cagrilintide · TFC. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and…
The pharmacy is accredited and I have verified that on the accreditor register. I keep seeing this stated as a fact with no explanation attached, and unexplained…
The particulars: BCH · SWB · South Africa. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints…
Stated plainly: dulaglutide · 4 °C. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the…
This is my second independent submission on material from the same supplier. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware…
Details up front: reflux · tirzepatide · SURMOUNT-3. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
Setup, so nobody has to ask: Hangzhou · the United Kingdom. This is presented as though it settles something, and I am not convinced it does. I have two documents…
What I am working with: Hangzhou · Singapore. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Details up front: a GLP-1 receptor agonist · sixteen weeks · 30 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may…
Numbers first: 99.1% · lot-specific certificate. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I would like to understand the steps well enough to explain them to someone…
Setup, so nobody has to ask: an HPLC purity test · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone…
What I am working with: batch certificate · QSC. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
What I am working with: semaglutide · twelve weeks. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…
Conditions: constipation · 900 kcal. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this…
I have kept a symptom diary against dose dates, which turns out to have been the useful thing. The figures are clear enough; the question is what they mean and what…
Conditions: 97.6% · liraglutide. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. I want the working, not the result — I need to be able to redo it…
The particulars: fibrillation · ecnoglutide · 2–8 °C. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review…
For reference: cystatin C · creatinine · a GLP-1 receptor agonist. I am trying to choose between two options that are usually discussed as though only one exists. I…